Atropine Articles
Bioniche acquires Baxter's Enlon line
7 July 2008
Meridian's Duodote gains FDA clearance
9 October 2006
King receives approval of sNDA for AtroPen
30 June 2003
Terapia to produce injectables
30 August 2001
UK MCA proposes POM-to-P switches
16 August 2001
Britoflex For Opiate Dependency
24 April 1995
FDA Regulations On Drug Promotion
13 February 1995
Showing 1-9 of 9 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
